Posts

Posted on

Alcoa Furthers Approvals Modernization with Australian Government

Alcoa Furthers Approvals Modernization with Australian Government

PERTH, Australia–(BUSINESS WIRE)–
Alcoa Corporation (NYSE: AA, ASX: AAI) (“Alcoa” or the “Company”), today announced Alcoa of Australia has agreed with the Australian Federal Government to further modernize the approvals framework for its Western Australian mining activities under Australia’s federal Environment Protection and Biodiversity Conservation Act (EPBC Act).

Alcoa of Australia will undertake a Strategic Assessment of current and potential future mining areas through to 2045, supported by the Government’s recent changes to the EPBC Act. The assessment will provide a holistic view of potential impacts to significant flora and fauna over a broad geographic area and will provide stakeholders with greater clarity about the long-term future of mining operations.

Operations at the Huntly and Willowdale mines will continue while the Strategic Assessment takes place under a National Interest Exemption (NIE) granted by the Australian Federal Government. Alcoa of Australia will continue to limit clearing to 800 hectares per year, increase annual rates of new rehabilitation to 1,000 hectares per year by 2027 and will deliver environmental offsets according to EPBC Act requirements.

“We are committed to responsible operations and welcome this important step in transitioning our approvals to a contemporary assessment process that provides increased certainty for our operations and our people into the future,” said Alcoa President and CEO William F. Oplinger. “We appreciate the Government’s recognition of the important contributions of our operations to the Australian economy. We’re proud of our more than 60 years as a leading Australian aluminum producer and the role we are now playing in support of critical minerals production.”

While Alcoa of Australia maintains it has operated in accordance with the EPBC Act, it has agreed to pay $36 (A$55) million through enforceable undertakings that acknowledge historical clearing. The funding supports the health of the Northern Jarrah Forest, including programs and research that improve habitat for threatened species and control invasive flora and fauna. Alcoa of Australia remains dedicated to previously announced environmental commitments:

Alcoa of Australia provides direct and indirect employment for approximately 5,500 people and supports thousands more jobs in the communities where it operates. In 2024, the Australian operations invested A$2.7 billion with over 1,700 Australian suppliers. More than 70 percent of revenue generated by the Company in Australia in 2024 stayed in Australia via wages, local spend, taxes and royalties.

The Strategic Assessment does not impact the ongoing accredited environmental assessment of the future Myara North and Holyoake mine regions of the Huntly mine under both Western Australian (WA) State and Australian Federal environmental legislation. The Company is committed to continuing to work collaboratively with stakeholders to achieve Ministerial decisions by the end of 2026 and anticipates that mining in these new major mine regions will commence no earlier than 2029. Until then, the Company expects bauxite quality will remain similar to recent grades.

The Company will record an incremental charge of $19 million ($13 million after-tax, or $0.05 per share) to previously reported Cost of goods sold for the fourth quarter of 2025, to adjust environmental reserves related to the enforceable undertakings. Associated cash outlays for the full provision of $36 (A$55) million are expected in 2026.

About Alcoa Corporation

Alcoa (NYSE: AA; ASX: AAI) is a global industry leader in bauxite, alumina and aluminum products with a vision to build a legacy of excellence for future generations. With a values-based approach that encompasses integrity, operating excellence, care for people and courageous leadership, our purpose is to Turn Raw Potential into Real Progress. Since developing the process that made aluminum an affordable and vital part of modern life, our talented Alcoans have developed breakthrough innovations and best practices that have led to greater efficiency, safety, sustainability and stronger communities wherever we operate.

Dissemination of Company Information

Alcoa intends to make future announcements regarding company developments and financial performance through its website, www.alcoa.com, as well as through press releases, filings with the Securities and Exchange Commission, conference calls, media broadcasts, and webcasts. Alcoa does not incorporate the information contained on, or accessible through, its corporate website into this press release.

Cautionary Statement on Forward-Looking Statements

This press release contains statements that relate to future events and expectations and as such constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include those containing such words as “aim,” “ambition,” “anticipates,” “believes,” “could,” “develop,” “endeavors,” “estimates,” “expects,” “forecasts,” “goal,” “intends,” “may,” “outlook,” “plans,” “potential,” “projects,” “reach,” “seeks,” “sees,” “should,” “targets,” “will,” “working,” “would,” or other words of similar meaning. All statements by Alcoa that reflect expectations, assumptions or projections about the future, other than statements of historical fact, are forward-looking statements. Forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties, and changes in circumstances that are difficult to predict. Although Alcoa believes that the expectations reflected in any forward-looking statements are based on reasonable assumptions, it can give no assurance that these expectations will be attained, and it is possible that actual results may differ materially from those indicated by these forward-looking statements due to a variety of risks and uncertainties. Factors which could cause actual results to differ from such forward-looking statements include, but are not limited to, industry, global, economic and other conditions. Additional information concerning factors that could cause actual results to differ materially from those projected in the forward-looking statements is contained in Alcoa’s filings with the Securities and Exchange Commission. Alcoa disclaims any obligation to update publicly any forward-looking statements, whether in response to new information, future events or otherwise, except as required by applicable law.

Investor Contact:

Jason Duty

+1-724-316-4366

[email protected]

Media Contact:

Sarah Ayer

+1-412-965-7622

[email protected]

Australia Media Contact:

Jodie Read

+61 (0)404 800 335

[email protected]

KEYWORDS: Pennsylvania North America United States Asia Pacific Australia Australia/Oceania

INDUSTRY KEYWORDS: Natural Resources Environment Mining/Minerals

MEDIA:

Logo
Logo
Posted on

Getty Realty Corp. Announces Pricing of Public Offering of 4,000,000 Shares of Common Stock

NEW YORK, Feb. 17, 2026 (GLOBE NEWSWIRE) — Getty Realty Corp. (NYSE: GTY) (the “Company”), a net lease REIT focused on convenience and automotive retail real estate, today announced the pricing of an underwritten public offering of an aggregate of 4,000,000 shares of its common stock sold on a forward basis in connection with the forward sale agreements described below, for gross proceeds of approximately $131 million. The forward purchasers (or their affiliates) and the Company have also granted the underwriters of the offering a 30-day option to purchase up to an additional 600,000 shares of common stock. The offering is expected to close on February 19, 2026, subject to customary closing conditions.

J.P. Morgan and Wells Fargo Securities acted as book-running managers for the offering.

In connection with the offering of shares of its common stock, the Company expects to enter into separate forward sale agreements with each of J.P. Morgan Securities LLC and Wells Fargo Securities (or their respective affiliates), each referred to in this capacity as the forward purchaser. In connection with such forward sale agreements, the forward purchasers (or their affiliates) are expected to borrow from third parties and sell to the underwriters an aggregate of 4,000,000 shares of the Company’s common stock (or 4,600,000 shares if the underwriters’ option is exercised in full and the Company elects to execute additional forward sale agreements). Pursuant to the terms of each forward sale agreement, and subject to its right to elect cash or net share settlement, the Company is obligated to issue and deliver, upon physical settlement of such forward sale agreement on one or more dates specified by the Company, the number of shares of the Company’s common stock underlying such forward sale agreement in exchange for a cash payment per share equal to the forward sale price under such forward sale agreement. The Company expects to physically settle the forward sale agreements and receive proceeds, subject to certain adjustments, from the sale of its shares of common stock upon one or more such physical settlements within approximately one year from the date of the prospectus supplement relating to the offering.

The Company will not initially receive any proceeds from the sale of shares of its common stock by the forward purchasers (or their affiliates). The Company intends to use the net proceeds from the offering and the net proceeds, if any, received upon the settlement of the forward sale agreements to fund property acquisitions, to repay indebtedness outstanding under its revolving credit facility, for working capital and other general corporate purposes, or a combination of the foregoing.

An automatic shelf registration statement on Form S-3 relating to the public offering of the shares of common stock described above was filed with the Securities and Exchange Commission (the “SEC”) and became effective on January 5, 2024. A preliminary prospectus supplement relating to the offering has been filed with the SEC. When available, copies of the prospectus supplement and related base prospectus for the offering may be obtained on the website of the SEC, www.sec.gov, or by contacting J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by email at [email protected] and [email protected]; or Wells Fargo Securities, 90 South 7th Street, 5th Floor, Minneapolis, MN 55402, at 800-645-3751 (option #5) or email a request to [email protected].

This press release shall not constitute an offer to sell or the solicitation of an offer to buy any shares of common stock, nor shall there be any sale of such common stock in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.

The offering of these securities may be made only by means of a prospectus and related prospectus supplement meeting the requirements of Section 10 of the Securities Act of 1933, as amended.


Forward-Looking Statements

CERTAIN STATEMENTS CONTAINED HEREIN MAY CONSTITUTE “FORWARD-LOOKING STATEMENTS” WITHIN THE MEANING OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995. WHEN THE WORDS “BELIEVES,” “EXPECTS,” “PLANS,” “PROJECTS,” “ESTIMATES,” “ANTICIPATES,” “PREDICTS,” “OUTLOOK” AND SIMILAR EXPRESSIONS ARE USED, THEY IDENTIFY FORWARD-LOOKING STATEMENTS. THESE FORWARD-LOOKING STATEMENTS ARE BASED ON MANAGEMENT’S CURRENT BELIEFS AND ASSUMPTIONS AND INFORMATION CURRENTLY AVAILABLE TO MANAGEMENT AND INVOLVE KNOWN AND UNKNOWN RISKS, UNCERTAINTIES AND OTHER FACTORS WHICH MAY CAUSE THE ACTUAL RESULTS, PERFORMANCE OR ACHIEVEMENTS OF THE COMPANY TO BE MATERIALLY DIFFERENT FROM ANY FUTURE RESULTS, PERFORMANCE OR ACHIEVEMENTS EXPRESSED OR IMPLIED BY THESE FORWARD-LOOKING STATEMENTS. EXAMPLES OF FORWARD-LOOKING STATEMENTS INCLUDE BUT ARE NOT LIMITED TO STATEMENTS REGARDING THE EXPECTED SETTLEMENT OF THE FORWARD SALE AGREEMENTS AND THE USE OF PROCEEDS FROM THE OFFERING AND ANY PROCEEDS RECEIVED FROM THE SETTLEMENT OF THE FORWARD SALE AGREEMENTS.

INFORMATION CONCERNING FACTORS THAT COULD CAUSE THE COMPANY’S ACTUAL RESULTS TO DIFFER MATERIALLY FROM THESE FORWARD-LOOKING STATEMENTS CAN BE FOUND ELSEWHERE IN THIS PRESS RELEASE, INCLUDING, WITHOUT LIMITATION, THOSE STATEMENTS IN THE COMPANY’S PERIODIC REPORTS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION. THE COMPANY UNDERTAKES NO OBLIGATION TO PUBLICLY RELEASE REVISIONS TO THESE FORWARD-LOOKING STATEMENTS TO REFLECT FUTURE EVENTS OR CIRCUMSTANCES OR REFLECT THE OCCURRENCE OF UNANTICIPATED EVENTS.


About Getty Realty Corp.

Getty Realty Corp. is a publicly traded, net lease REIT specializing in the acquisition, financing and development of convenience, automotive and other single tenant retail real estate. As of December 31, 2025, the Company’s portfolio included 1,174 freestanding properties located in 44 states across the United States and Washington, D.C.

Contact:   Investor Relations  
    (646) 349-0598  
    [email protected]  



Posted on

HCW Biologics Announces Pricing of $1.5 Million Follow-On Offering Priced At-The-Market Under NASDAQ Rules

MIRAMAR, Fla., Feb. 17, 2026 (GLOBE NEWSWIRE) — HCW Biologics Inc. (the “Company”), (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies to extend health span by targeting the link between chronic inflammation and disease, today announced the pricing of its follow-on offering of an aggregate of 2,477,292 units at a purchase price of $0.6055 per unit priced at-the-market under Nasdaq rules. Each unit consists of one share of common stock (or pre-funded warrant in lieu thereof) and one warrant, each to purchase one share of common stock. The warrant will have an exercise price of $0.6055 per share, will be exercisable upon shareholder approval, and will expire on the five-year anniversary from such date of shareholder approval. The shares of common stock (or pre-funded warrants) and the warrant comprising the units are immediately separable and will be issued separately in this offering. The closing of the offering is expected to occur on or about February 19, 2026, subject to the satisfaction of customary closing conditions.

Maxim Group LLC is acting as the sole placement agent for the offering.

The gross proceeds from the offering, before deducting the placement agent’s fees and other offering expenses, are expected to be approximately $1.5 million. The Company intends to use the net proceeds from this offering for funding preclinical and clinical development, including the clinical trials for HCW9302, and general corporate purposes.

In addition, the Company has entered into a privately negotiated agreement with the holder of certain existing outstanding warrants to purchase up to 3,020,410 shares of common stock (the “Existing Warrants”) to reduce the exercise price of such Existing Warrants from $2.41 per share to $0.6055 per share. The reduction of the exercise price of the Existing Warrants is subject to shareholder approval.

The securities described above are being offered pursuant to a registration statement on Form S-1, as amended (File No. 333-293396), which was declared effective by the Securities and Exchange Commission (the “SEC”) on February 17, 2026. The offering is being made only by means of a prospectus which forms a part of the effective registration statement. A preliminary prospectus relating to the offering has been filed with the SEC. Electronic copies of the final prospectus, when available, may be obtained on the SEC’s website at www.sec.gov and may also be obtained by contacting Maxim Group LLC at 300 Park Avenue, 16th Floor, New York, NY 10022, Attention: Prospectus Department, or by telephone at (212) 895-3745 or by email at [email protected].

This press release shall not constitute an offer to sell or a solicitation of an offer to buy any of the securities described herein, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.

About HCW Biologics:

HCW Biologics Inc. (NASDAQ: HCWB) is a clinical-stage biopharmaceutical company developing proprietary immunotherapies to treat diseases promoted by chronic inflammation, especially age-related and senescence-associated diseases. The Company’s immunotherapeutics represent a new class of drugs that it believes have the potential to fundamentally change the treatment of cancer and many other diseases and conditions that are promoted by chronic inflammation — and in doing so, improve patients’ quality of life and potentially extend longevity. Chronic inflammation, including inflammaging, is believed to be a significant contributing factor to senescence-associated diseases and conditions that diminish health span, including many types of cancer, autoimmune diseases, and neurodegenerative diseases, as well as many indications that impact quality-of-life that are not life-threatening. The Company’s lead product candidate, HCW9302, was developed using the Company’s legacy TOBI™ (Tissue factOr-Based fusIon) platform. The Company has created another drug discovery technology, the TRBC platform, which is not based on Tissue Factor. The TRBC platform has the capability to construct immunotherapeutics that not only activate and target immune responses but are also equipped with receptors that specifically target cancerous or infected cells. This platform is a versatile scaffold that enables the creation of multiple classes of immunotherapeutic compounds: Class I: Multi-Functional Immune Cell Stimulators; Class II: Second-Generation Immune Checkpoint Inhibitors; Class III: Multi-Specific Targeting Fusions and Enhanced Immune Cell Engagers. These novel immunotherapeutics are being developed for treatment of a wide range of disease indications, including oncology, autoimmune diseases, and improving quality of life conditions. The Company has constructed over 50 molecules using the TRBC platform. HCW9302 is the lead product candidate for the Company’s clinical development program for autoimmune diseases and other proinflammatory conditions. The Company has dosed the first patient in a Company-sponsored, multi-center Phase 1 clinical trial to evaluate HCW9302 in an autoimmune disease (NCT07049328). The IND-enabling process is underway for three TRBC-based molecules which were selected as the lead product candidates for other clinical development programs in cancer and age-related diseases based on promising preclinical data. The Company has two licensing programs in which it has licensed exclusive rights for some of its proprietary molecules.

Forward-Looking Statements

Statements in this press release contain “forward-looking statements” that are subject to substantial risks and uncertainties. These statements are made under the “safe harbor” provisions of the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements contained in this press release may be identified by the use of words such as “anticipate,” “expect,” “believe,” “will,” “may,” “should,” “estimate,” “project,” “outlook,” “forecast” or other similar words and include, the statements on the closing of the offering and the satisfaction of closing conditions and use of proceeds in the offering, the Company’s ability to develop new immunotherapeutic treatments for non-oncology or oncology indications; the capabilities of the Company’s new platform and the effectiveness of new fusion proteins developed using the new platform. Forward-looking statements are based on the Company’s current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. Factors that could cause actual results to differ include, but are not limited to, the risks and uncertainties that are described in the section titled “Risk Factors” in the annual report on Form 10-K filed with the United States Securities and Exchange Commission (the “SEC”) on March 28, 2025 and in other filings filed from time to time with the SEC. Forward-looking statements contained in this press release are made as of this date, and the Company undertakes no duty to update such information except as required under applicable law.

Company Contact:

Rebecca Byam
CFO
HCW Biologics Inc.
[email protected]



Posted on

Westlake Epoxy Expands Distribution Relationship with Brenntag to India

Westlake Epoxy Expands Distribution Relationship with Brenntag to India

HOUSTON–(BUSINESS WIRE)–
Westlake Corporation (NYSE: WLK) today announced that Westlake Epoxy will expand its long‑standing distribution relationship with Brenntag to South and West India. The agreement builds on a successful collaboration across Europe, North and South America, and Southeast Asia, extending Westlake Epoxy’s reach into one of the world’s fastest‑growing coatings, adhesives and construction markets.

Under the expanded collaboration, Brenntag will distribute Westlake Epoxy’s established portfolio of epoxy solutions for coatings, adhesives and construction applications, including the EPON™, EPIKOTE™, EPIKURE™ and EPI‑REZ™ product lines. Customers are expected to benefit from reliable local supply, technical service and application‑focused formulation support tailored to regional requirements.

India’s coatings, adhesives and construction sectors continue to grow, driven by infrastructure investment, urbanization and increasing performance expectations. By combining Westlake Epoxy’s proven epoxy technologies with Brenntag’s regional presence and technical capabilities, the collaboration strengthens support for customers addressing evolving performance, processing and regulatory needs.

“Expanding our collaboration with Brenntag into India allows us to support customers more closely in a high‑growth market,” said Brian Powers, Vice President, Westlake Epoxy. “Brenntag’s deep market understanding, technical expertise and strong customer reach makes them a strong partner for the Indian market. This collaboration enables us to serve customers more closely and respond effectively to local application and performance requirements.”

“With our presence in South and West India and strong technical capabilities, we are well positioned to support customers with tailored epoxy solutions for coatings, adhesives and construction, while Westlake Epoxy’s reliable, portfolio supports further business growth,” said Sanjay Karkhanis, Regional President, Material Science Brenntag APAC. “The expansion of our collaboration with Westlake Epoxy into India strengthens our Material Science offering in a fast-growing market.”

About Westlake Epoxy

Westlake Epoxy, a Westlake company, is a global leader in epoxy resins, curing agents and specialty systems for higher‑performance materials, coatings and composites, delivering strength, durability, chemical and corrosion resistance, and stronger adhesion performance in demanding applications. The EpoVIVE™ portfolio of epoxy phenolic resins and curing agents reflects Westlake Epoxy’s dedication to reducing the environmental impact of its products. Serving industries such as coatings, construction, adhesives, automotive, civil engineering, composites, electronics and renewable energy, Westlake Epoxy supports customers worldwide with advanced materials and application expertise. For more information, visit Frontpage | Westlakeepoxy or contact [email protected]

About Westlake

Westlake Corporation (NYSE: WLK) is a global manufacturer and supplier of materials and innovative products that enhance life every day. Headquartered in Houston, with operations in Asia, Europe, and North America, we provide building blocks for vital solutions — from housing and construction, to packaging and healthcare, to automotive and consumer. For more information, visit the company’s web site at www.westlake.com.

About Brenntag

Brenntag is the global market leader in chemicals and ingredients distribution, connecting customers and suppliers worldwide. Headquartered in Essen, Germany, it has over 18,100 employees at around 600 sites in more than 70 countries. Through its two divisions, Brenntag Essentials and Brenntag Specialties, the company offers a broad portfolio of chemicals and ingredients plus tailored technical, regulatory, supply chain, and digital solutions, and it is committed to an ambitious sustainability agenda. For more information, visit www.brenntag.com

Media contact:

Dr. Oliver Mieden,

Westlake Germany GmbH & Co. KG,

Phone: +49 (0)89 96103-282, E-mail: [email protected]

Mila Hierner,

Westlake Epoxy Belgium BV,

Phone: +32 10 48 22 50, E-mail: [email protected]

KEYWORDS: United States India North America Asia Pacific Europe Germany Texas

INDUSTRY KEYWORDS: Other Manufacturing Construction & Property Finance Packaging Chemicals/Plastics Automotive Manufacturing Professional Services Aerospace Manufacturing Other Construction & Property

MEDIA:

Logo
Logo
Posted on

CECO Environmental to Release Fourth Quarter Earnings and Host Conference Call on February 24

ADDISON, Texas, Feb. 17, 2026 (GLOBE NEWSWIRE) — CECO Environmental Corp. (Nasdaq: CECO), a leading environmentally focused, diversified industrial company whose solutions protect people, the environment and industrial equipment, today announced that it will report its fourth quarter 2025 financial results on February 24, 2026, premarket. The Company will also host its earnings call starting at 8:30 a.m. Eastern Time (7:30 a.m. CT). The Company’s financial results and presentation will be posted on its website at www.cecoenviro.com.

The details for the webcast are:

When: Tuesday, February 24 at 8:30 a.m. Eastern Time

Where: https://edge.media-server.com/mmc/p/esi9fzv8

How: Live over the internet – Simply log on to the web at the address above

Register to receive the dial-in info and a unique pin: https://register-conf.media-server.com/register/BIef187ad40fff4b6eaf15a109421408ae

A replay of the conference call will be available on the Company’s website shortly after the live webcast has concluded.

ABOUT CECO ENVIRONMENTAL

CECO Environmental is a leading environmentally focused, diversified industrial company, serving a broad landscape of industrial air, industrial water, and energy transition markets globally through its key business segments: Engineered Systems and Industrial Process Solutions. Providing innovative technology and application expertise, CECO helps companies grow their business with safe, clean, and more efficient solutions that help protect people, the environment and industrial equipment. In regions around the world, CECO works to improve air quality, optimize the energy value chain, and provide custom solutions for applications in power generation, petrochemical processing, refining, midstream gas transport and treatment, electric vehicle and battery production, metals and mineral processing, polysilicon production, battery recycling, beverage can production, and produced and oily water/wastewater treatment along with a wide range of other industrial applications. CECO is listed on Nasdaq under the ticker symbol “CECO.” Incorporated in 1966, CECO’s global headquarters is in Addison, Texas. For more information, please visit www.cecoenviro.com.

CECO Environmental Investor Contact:

Marcio Pinto
Vice President – Financial Planning & Investor Relations
888-990-6670
[email protected]
        
Steven Hooser and Jean Marie Young
Three Part Advisors
214-872-2710
[email protected]

CECO Environmental Media and Communication Contact:

Rachael Gallodoro
214-350-2992
[email protected]



Posted on

Sompo Group and Guidewire Enter Long-Term Agreement to Enhance Global Operations with Guidewire Cloud Platform

Sompo Group and Guidewire Enter Long-Term Agreement to Enhance Global Operations with Guidewire Cloud Platform

Agreement marks the start of a new era in insurance experiences driven by AI

TOKYO & SAN MATEO, Calif.–(BUSINESS WIRE)–
Sompo Group (Sompo), a leading Japanese insurance and reinsurance company, and Guidewire (NYSE: GWRE) today announced a long-term agreement supporting Sompo’s global adoption of Guidewire Cloud Platform applications and tools. The partnership will unify decision-making across Sompo’s local and country-specific entities, enabling them to migrate existing Guidewire applications from on-premises environments and implement new solutions directly on Guidewire Cloud Platform. Under the new agreement, Sompo will leverage Guidewire to optimize operations, and increase the power and reach of decision making across its lines of business.

Accelerating Global Decision-Making and Profitable Growth

Sompo and Guidewire have a long-standing partnership, with multiple Sompo entities leveraging Guidewire in core operations. This new agreement strengthens this strategic relationship and reinforces Guidewire’s role in supporting Sompo’s core processing. It will add the reach of artificial intelligence (AI)-powered applications and capabilities Guidewire offers on an open trusted core platform, helping operationalize GenAI at scale and delivering business impact across the insurance lifecycle for the global Sompo enterprise. The initial focus will begin with Sompo’s global commercial businesses, which will migrate Guidewire ClaimCenter and Guidewire PolicyCenter from on-premises to Guidewire Cloud Platform, and a broad expansion across a wide range of solution capabilities at Sompo Direct Insurance, Inc. in Japan.

Daniel Englberger, Chief Operating Officer for Sompo’s international P&C business said, “Guidewire has been a trusted partner throughout our 12-year relationship, supporting not only our insurance technology needs but also providing guidance on our long-term strategy. We are confident in the Guidewire product roadmap and look forward to working together on this transformation.”

Reimagining the Customer Experience for Direct Insurance in Japan

In Japan, Sompo Direct Insurance, Inc., a direct-to-consumer P&C insurer, has selected PolicyCenter, BillingCenter, Jutro Digital Platform, and Data Studio as its new core systems for policy administration, underwriting, and billing. These solutions will support Sompo Direct’s automobile, homeowner, and earthquake lines of business. Sompo Direct implemented ClaimCenter on Guidewire Cloud Platform in 2024.

“Our previous policy administration, underwriting, and billing systems faced challenges related to scalability, efficiency, and maintaining long-term accuracy,” said Katsuyuki Tajiri, Deputy President of Sompo Japan Insurance and Senior Vice President of Sompo Holdings responsible for the Direct Insurance Business and Overseas M&A. “Guidewire Cloud Platform will improve operational efficiency, strengthen data analytics, and support sound decision-making. It will also enable us to deliver better service and faster response times to our customers, enhancing their engagement with us. We were particularly drawn to the platform’s scalability, its ease of integration with existing systems, and its ability to continuously expand to support ongoing efficiency improvements.”

Mike Rosenbaum, Chief Executive Officer of Guidewire, said, “We are grateful to Sompo Group for their continued commitment and trust in Guidewire to provide the speed, flexibility, and capability needed to support their growth. We are excited to work alongside Sompo in their global mission to protect the wellbeing and financial security of the people and enterprises they serve by delivering a reliable technology foundation across core systems, data, digital engagement, and AI.”

“We are honored that Sompo Group has selected Guidewire Cloud Platform for its operations in Japan and globally,” said Miyuki Ebata, Country Manager of Guidewire Japan. “Our commitment is to support Sompo in enhancing customer satisfaction and operational efficiency. In Japan, we will help our customers realize value quickly by providing secure, low-risk implementations and migration programs.”

About Sompo Group

Building on over 137 years of innovation, Sompo Group is a leading integrated (re)insurance and financial services group committed to delivering health, wellbeing and financial protection to businesses and individuals worldwide. Sompo Group comprises Sompo Holdings, Inc. (Sompo Holdings) and its subsidiaries, providing solutions in commercial and consumer property, casualty and speciality insurance and reinsurance globally, and life insurance and nursing care in Japan.

Its insurance subsidiaries have excellent financial strength as evidenced by ratings of A+ from A.M. Best and A+ from Standard & Poor’s. Shares of Sompo Holdings are listed on the Tokyo Stock Exchange (8630.T).

To learn more please follow us on LinkedIn or visit Sompo-hd.com.

About Guidewire Software

Guidewire is the platform P&C insurers trust to engage, innovate, and grow efficiently. More than 570 insurers in 43 countries, from new ventures to the largest and most complex in the world, rely on Guidewire products. With core systems leveraging data and analytics, digital, and artificial intelligence, Guidewire defines cloud platform excellence for P&C insurers.

We are proud of our unparalleled implementation record, with 1,700+ successful projects supported by the industry’s largest R&D team and partner ecosystem. Our marketplace represents the largest partner community in P&C, where customers can access hundreds of applications to accelerate integration, localization, and innovation.

For more information, please visit www.guidewire.com/ and follow us on X and LinkedIn.

NOTE: For information about Guidewire’s trademarks, visit https://www.guidewire.com/legal-notices.

Albert Lin

Public Relations Manager

Guidewire Software, Inc.

+1.415.205.4214

[email protected]

Shu Nakamura

Manager, Japan Media Relations, Sompo Holdings

[email protected]

Mike Jones

Global Head of Media Relations, Sompo

+44 7765 901899

[email protected]

KEYWORDS: United States Japan North America Asia Pacific California

INDUSTRY KEYWORDS: Apps/Applications Technology Insurance Human Resources Professional Services Software Internet Data Management Artificial Intelligence Other Professional Services

MEDIA:

Logo
Logo
Posted on

INVESTOR ALERT: PayPal Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead the PayPal Class Action Lawsuit – RGRD Law

SAN DIEGO, Feb. 17, 2026 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that the PayPal class action lawsuit seeks to represent purchasers or acquirers of PayPal Holdings, Inc. (NASDAQ: PYPL) common stock between February 25, 2025 and February 2, 2026, inclusive (the “Class Period”). Captioned Goodman v. PayPal Holdings, Inc., No. 26-cv-01381 (N.D. Cal.), the PayPal class action lawsuit charges PayPal and certain of PayPal’s top current and former executives with violations of the Securities Exchange Act of 1934.

If you suffered substantial losses and wish to serve as lead plaintiff of the

PayPal

class action lawsuit, please provide your information here:


https://www.rgrdlaw.com/cases-paypal-holdings-class-action-lawsuit-pypl.html

You can also contact attorney

J.C. Sanchez

of Robbins Geller by calling 800/449-4900 or via e-mail at

[email protected]

.

CASE ALLEGATIONS: PayPal operates a technology platform that enables digital payments for merchants and consumers.

The PayPal class action lawsuit alleges that defendants throughout the Class Period created the false impression that they possessed reliable information pertaining to PayPal’s projected revenue outlook and anticipated growth while also minimizing risk from seasonality and macroeconomic fluctuations. In truth, PayPal’s optimistic plan for growth through various initiatives to bolster PayPal’s Branded Checkout offerings fell short of reality as the 2027 targets were not achievable under the tenure of defendant James Alexander Chriss as CEO; they required both an unrealistically stable consumer landscape and strong execution with clear direction from PayPal and its management, the complaint alleges.

The PayPal class action lawsuit further alleges that on February 3, 2026, PayPal announced its financial results for the fourth quarter and full fiscal year 2025, disclosing disappointing earnings results with worsening performance in Branded Checkout and the withdrawal of its 2027 financial targets provided one year before. PayPal allegedly attributed its results and lowered guidance to a combination of macroeconomic factors, competition, and “‘operational and deployment issues’ across all regions.” The complaint alleges that PayPal also revealed the transition of its CEO, defendant James Alexander Chriss. On this news, the price of PayPal common stock fell more than 20%, according to the complaint.

THE LEAD PLAINTIFF PROCESS: The Private Securities Litigation Reform Act of 1995 permits any investor who purchased or acquired PayPal common stock during the Class Period to seek appointment as lead plaintiff in the PayPal class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class. A lead plaintiff acts on behalf of all other class members in directing the PayPal investor class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the PayPal shareholder class action lawsuit. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the PayPal class action lawsuit.

ABOUT ROBBINS GELLER: Robbins Geller Rudman & Dowd LLP is one of the world’s leading law firms representing investors in securities fraud and shareholder rights litigation. Our Firm ranked #1 on the most recent ISS Securities Class Action Services Top 50 Report, recovering more than $916 million for investors in 2025. This marks our fourth #1 ranking in the past five years. And in those five years alone, Robbins Geller recovered $8.4 billion for investors – $3.4 billion more than any other law firm. With 200 lawyers in 10 offices, Robbins Geller is one of the largest plaintiffs’ firms in the world, and the Firm’s attorneys have obtained many of the largest securities class action recoveries in history, including the largest ever – $7.2 billion – in In re Enron Corp. Sec. Litig. Please visit the following page for more information:


https://www.rgrdlaw.com/services-litigation-securities-fraud.html

Past results do not guarantee future outcomes.

Services may be performed by attorneys in any of our offices. 

Contact:
        Robbins Geller Rudman & Dowd LLP
        J.C. Sanchez
        655 W. Broadway, Suite 1900, San Diego, CA 92101
        800-449-4900
        [email protected]



Posted on

TJ Maxx and JP Morgan Chase Bank Renew Long-Term Retail Leases With Empire State Realty Trust Which Total 68,120 Square Feet

TJ Maxx and JP Morgan Chase Bank Renew Long-Term Retail Leases With Empire State Realty Trust Which Total 68,120 Square Feet

NEW YORK–(BUSINESS WIRE)–Empire State Realty Trust, Inc. (NYSE: ESRT) announced today that it signed long-term renewal leases with TJ Maxx and JP Morgan Chase Bank for retail spaces for 46,437 and 21,683 square feet, respectively.

TJ Maxx signed a renewal lease for its 46,437 square foot space at 250 W. 57th Street in Q4 2025. Richard Skulnik of RIPCO represented TJ Maxx in the lease negotiations.

JP Morgan Chase Bank signed a renewal lease for its 21,683 square foot space at One Grand Central Place in Q1 2026. Michael O’Neill of Cushman & Wakefield represented JP Morgan Chase Bank in the lease negotiations.

“These long-term recommitments from TJ Maxx and JP Morgan Chase reinforce the strength and stability of ESRT’s Midtown portfolio,” said Fred C. Posniak, SVP, leasing at ESRT. “In the heart of New York City’s vibrant Midtown, where unmatched foot traffic and energy drive business success, ESRT creates value through its partnership-driven approach to maintain these relationships with leading companies.”

ESRT’s Posniak and Alec Stone represented the property owner on both transactions.

More information about ESRT’s portfolio, and current NYC retail availability, can be found online.

About Empire State Realty Trust

Empire State Realty Trust, Inc. (NYSE: ESRT) is a NYC-focused REIT that owns and operates a portfolio of well-leased, top of tier, modernized, amenitized, and well-located office, retail, and multifamily assets. ESRT’s flagship Empire State Building, the “World’s Most Famous Building,” features its iconic Observatory, ranked the #1 Top Attraction in New York City for the fourth consecutive year in Tripadvisor’s 2025 Travelers’ Choice Awards: Best of the Best Things to Do. The Company is a recognized leader in energy efficiency and indoor environmental quality. As of December 31, 2025, ESRT’s operating portfolio is comprised of approximately 7.6 million rentable square feet of office space, 0.8 million rentable square feet of retail space and 743 residential units. The Company also owns two properties that are being redeveloped with approximately 0.4 million rentable square feet of office space and 43 thousand rentable square feet of retail space. More information about Empire State Realty Trust can be found at esrtreit.com and by following ESRT on Facebook, Instagram, TikTok, X, and LinkedIn.

MEDIA:

Empire State Realty Trust

Jamie Heitner

212-400-3339

[email protected]

KEYWORDS: United States North America New York

INDUSTRY KEYWORDS: Commercial Building & Real Estate Construction & Property REIT

MEDIA:

Logo
Logo
Posted on

BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)

PALO ALTO, Calif., Feb. 17, 2026 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, today announced that on February 12, 2026, the compensation committee of BridgeBio’s board of directors approved equity grants to 34 new employees in restricted stock units for an aggregate of 76,701 shares of the Company’s common stock. One-fourth of the shares underlying each employee’s restricted stock units will vest on February 16, 2027, with one-twelfth of the remaining shares underlying each such employee’s restricted stock units vesting on a quarterly basis thereafter, in each case, subject to each such employee’s continued employment with the Company or one of its subsidiaries on such vesting dates.

The above-described awards were each granted as an inducement material to the employees entering into employment with the Company in accordance with Nasdaq Listing Rule 5635(c)(4) and were granted pursuant to the terms of the Plan. The Plan was adopted by BridgeBio’s board of directors in November 2019, and amended and restated on February 10, 2023 and on December 13, 2023.

About BridgeBio Pharma, Inc.

BridgeBio exists to develop transformative medicines for genetic conditions. Millions of people worldwide living with genetic conditions lack treatment options, often because drug development for small patient populations can be commercially challenging. We aim to bridge the gap between advancements in genetic science and meaningful medicines for underserved patient populations. Our decentralized, hub-and-spoke model is designed for speed, precision, and scalability. Autonomous and empowered teams focus on individual conditions, while a central hub provides the clinical, regulatory, and commercial capabilities needed to bring innovation to market. For more information, visit bridgebio.com and follow us on LinkedIn, X, Facebook, Instagram, YouTube, and TikTok.

BridgeBio Media Contact:

Bubba Murarka, Executive Vice President, Corporate Development
[email protected]
(650)-789-8220

BridgeBio Investor Contact:

Chinmay Shukla, Senior Vice President, Strategic Finance
[email protected]



Posted on

Armada Acquisition Corp. III Announces Pricing of $225,000,000 Initial Public Offering

Armada Acquisition Corp. III Announces Pricing of $225,000,000 Initial Public Offering

PHILADELPHIA–(BUSINESS WIRE)–
Armada Acquisition Corp. III (the “Company” or “AACI”) announced today that it priced its initial public offering of 22,500,000 units at $10.00 per unit. The units are expected to be listed on the Nasdaq Global Market (“Nasdaq”) and trade under the ticker symbol “AACIU” beginning on February 18, 2026. Each unit consists of one Class A ordinary share and one-half of one redeemable warrant. Each whole warrant entitles the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to adjustment. Only whole warrants are exercisable and will trade. Once the securities comprising the units begin separate trading, the Class A ordinary shares and warrants are expected to be listed on Nasdaq under the symbols “AACI” and “AACIW,” respectively.

AACI is led by Stephen P. Herbert, Chairman, Chief Executive Officer and Director, Douglas M. Lurio, President, Chief Financial Officer and Director, Mohammad A. Khan, Director, Thomas (Tad) A. Decker, Director, and Celso L. White, Director.

Cohen & Company Capital Markets, a division of Cohen & Company Securities, LLC, is acting as lead book-runner, and Northland Capital Markets is acting as joint book-runner for the offering. The Company has granted the underwriters a 45-day option to purchase up to an additional 3,375,000 units at the initial public offering price to cover over-allotments, if any. The offering is expected to close on February 19, 2026, subject to customary closing conditions.

The offering is being made only by means of a prospectus. When available, copies of the prospectus may be obtained by contacting Cohen & Company Capital Markets, 3 Columbus Circle, 24th Floor, New York, NY 10019, Attention: Prospectus Department, or by email at: [email protected] or Northland Securities, Inc., 150 South 5th Street, Suite 3300, Minneapolis, MN 55402.

A registration statement relating to the securities has been filed with the U.S. Securities and Exchange Commission (the “SEC”) and was declared effective on February 17, 2026. This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Armada Acquisition Corp. III

The Company is a special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or similar business combination with one or more businesses. Although the Company’s efforts to identify a prospective target business will not be limited to a particular industry or geographic region, the Company intends to focus on a target in the financial services (“FinTech”), Software-as-a-Service (“SaaS”), or generative artificial intelligence (“AI”) industries which the Company believes offer the most promising potential for acquisitions due to their strong growth and strategic alignment with our business goals.

Forward-Looking Statements

This press release contains statements that constitute “forward-looking statements,” including with respect to the proposed initial public offering and the anticipated use of net proceeds. No assurance can be given that the offering discussed above will be completed on the terms described, or at all, or that the net proceeds of the offering will be used as indicated. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company’s registration statement and preliminary prospectus for the offering filed with the SEC. Copies are available on the SEC’s website, www.sec.gov. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.

Investor Contact:

Mike Bishop

Bishop IR, LLC

[email protected]

KEYWORDS: Pennsylvania United States North America

INDUSTRY KEYWORDS: Professional Services Technology Software Finance Fintech Artificial Intelligence Internet

MEDIA: